Search Results: "PARP inhibitor"

• For Researchers

Honouring a giant of translational research: Stan Kaye

In 2016 we awarded our Lifetime Achievement in Cancer Research Prize to Professor Stan Kaye, who has made exceptional advances in cancer drug development. In 2016 we awarded our Lifetime Achievement in Cancer Research Prize to Professor Stan Kaye, who has made exceptional advances in cancer drug development.

19 May 2017

• Science & Technology

PARG inhibitors: tipping the scales with a new experimental drug

Our scientists are developing a new experimental drug to target how cancer cells repair their DNA, and upset cancer's balance. Our scientists are developing a new experimental drug to target how cancer cells repair their DNA, and upset cancer's balance.

16 March 2017

• Science & Technology

More breast cancer patients than previously thought could benefit from existing targeted treatment

As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates. As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates.

13 March 2017

• Health & Medicine

Ovarian cancer drug could target gene fault in brain tumours

A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest. A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest.

1 February 2017

• For Researchers

Future leaders and a lifetime in drug development: our research prizes

Last week we had the pleasure of awarding our Research Prizes to five exceptional researchers at our annual prizegiving ceremony at the NCRI Conference. Last week we had the pleasure of awarding our Research Prizes to five exceptional researchers at our annual prizegiving ceremony at the NCRI Conference.

16 November 2016

• Personal Stories

How your support is helping us beat breast cancer – Margaret’s story

The year is 2016, Breast Cancer Awareness Month is upon us, and right now, 8 in 10 women diagnosed with breast cancer will survive their disease for 10 years or more. The year is 2016, Breast Cancer Awareness Month is upon us, and right now, 8 in 10 women diagnosed with breast cancer will survive their disease for 10 years or more.

1 October 2016

• Science & Technology

CRT and SV Life Sciences form Artios Pharma to focus on DNA damage response

Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma. Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma.

21 September 2016

• Health & Medicine

Crashing cancer’s backup system – our progress so far

Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey? Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey?

12 September 2016

• Health & Medicine

Study opens door to targeted treatments for oesophageal cancer

Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments. Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments.

5 September 2016

• Health & Medicine
• Science & Technology

All women with ovarian cancer should be offered genetic testing – so why aren’t they?

Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why. Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why.

17 August 2016

• Health & Medicine
• Science & Technology

Dundee research explains drug resistance in ovarian cancer

Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments. Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.

10 August 2016

• For Researchers

A celebrated career in DNA repair: Tomas Lindahl

We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this. We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this.

10 August 2016